METASTATIC NEUROENDOCRINE TUMOR
Clinical trials for METASTATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a drug combo shrink Hard-to-Treat neuroendocrine tumors?
Disease control OngoingThis study tests whether adding the drug triapine to standard radioactive therapy (Lutathera) works better than Lutathera alone for people with advanced neuroendocrine tumors that have spread. About 94 adults with a specific type of these tumors will take part. The goal is to see…
Matched conditions: METASTATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:00 UTC
-
New drug combo shows promise for rare gut tumors
Disease control OngoingThis early-stage trial tests a new two-drug combination for people with advanced neuroendocrine tumors (NETs) that have spread. The study combines triapine, which may slow tumor growth, with a radioactive drug called lutetium Lu 177 dotatate that targets tumor cells directly. Abo…
Matched conditions: METASTATIC NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New drug shows promise in slowing carcinoid tumors
Disease control OngoingThis study tests a drug called pazopanib in 171 people with carcinoid tumors that are getting worse. The goal is to see if pazopanib can slow or stop tumor growth compared to a placebo. Participants take the drug daily and are monitored for how long their disease stays stable.
Matched conditions: METASTATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC